Latest Intellectual Property News

Syntara Limited offers existing shareholders a discounted share purchase plan to raise about $2 million, following a recent $8 million institutional placement to fund clinical trials and licensing.

Advanced Energy Minerals is ramping up its Quebec high purity alumina plant to 3,000 tpa by mid-2026, with plans to double capacity to 6,000 tpa by 2029 amid a tightening global market and supply deficit.

Pure Resources has launched an integrated Defence Materials Platform Strategy for its Garnet Hills Project, leveraging US government collaborations to diversify from commodity mining into advanced defence supply chains.

Fluence Corporation Limited (ASX: FLC) reports a 52% revenue surge in FY2025 driven by strategic growth in Smart Product Solutions and recurring revenue, alongside progress on a major Ivory Coast water treatment plant.

BPH Global inks binding deal with Temasek Innovation Holdings to validate its seaweed-based male vitality product through targeted biological assays, advancing regulatory and commercial ambitions.

BPH Global’s Indonesian unit has locked in a four-year MoU with ITBM to integrate student-driven operations and research at its Takalar coastal seaweed site, setting the stage for scaled commercial development and local collaboration.

Entropy Neurodynamics has bolstered its intellectual property portfolio with a new US provisional patent application for TRP-8803, following compelling Phase 2a data showing a 75% response rate in treatment-resistant IBS patients.

Nine Entertainment’s acquisition of QMS Media and sale of Nine Radio mark a strategic pivot, with strong Q3 digital and subscription revenue growth cushioning a cautious Q4 advertising environment.

Holista Colltech has partnered with Swang Chai Chuan to develop a nano-collagen production facility in Western Australia, marking a major step in commercialising its collagen technology with a $1.6 million initial investment.

BrainChip Holdings has signed a global IP license agreement with ASICLAND, enabling integration of its Akida neuromorphic AI technology into custom SoC designs with a royalty-based revenue model.

Light & Wonder (ASX:LNW) posted modest revenue growth in 2025, driven by Gaming and iGaming segments, while SciPlay revenue dipped slightly. The company completed its Grover acquisition, settled a $128 million IP dispute with Aristocrat, and transitioned to a sole ASX listing.

Recce Pharmaceuticals bolsters its clinical and commercial pipeline with a $5.3 million AUD R&D tax rebate, a second U.S. Army research agreement for its RECCE 327 Gel, and a key patent granted in Brazil, while progressing Phase 3 trials in Indonesia.